日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Macaca fascicularis Protein FAM200A (FAM200A), partial CSB-YP687018MOV
CSB-EP687018MOV
CSB-BP687018MOV
CSB-MP687018MOV
CSB-EP687018MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Dual specificity tyrosine-phosphorylation-regulated kinase 3 (DYRK3), partial CSB-YP687019MOV
CSB-EP687019MOV
CSB-BP687019MOV
CSB-MP687019MOV
CSB-EP687019MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis STE20-related kinase adapter protein alpha (STRADA) CSB-YP687020MOV
CSB-EP687020MOV
CSB-BP687020MOV
CSB-MP687020MOV
CSB-EP687020MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis AP-2 complex subunit mu (AP2M1) CSB-YP687021MOV
CSB-EP687021MOV
CSB-BP687021MOV
CSB-MP687021MOV
CSB-EP687021MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD2), partial CSB-YP687022MOV
CSB-EP687022MOV
CSB-BP687022MOV
CSB-MP687022MOV
CSB-EP687022MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Biogenesis of lysosome-related organelles complex 1 subunit 2 (BLOC1S2) CSB-YP687023MOV
CSB-EP687023MOV
CSB-BP687023MOV
CSB-MP687023MOV
CSB-EP687023MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Protein Spindly (CCDC99), partial CSB-YP687024MOV
CSB-EP687024MOV
CSB-BP687024MOV
CSB-MP687024MOV
CSB-EP687024MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis E3 ubiquitin-protein ligase Hakai (CBLL1) CSB-YP687025MOV
CSB-EP687025MOV
CSB-BP687025MOV
CSB-MP687025MOV
CSB-EP687025MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Uncharacterized protein C1orf111 homolog (QtsA-14887) CSB-YP687026MOV
CSB-EP687026MOV
CSB-BP687026MOV
CSB-MP687026MOV
CSB-EP687026MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis PRKCA-binding protein (PICK1) CSB-YP687027MOV
CSB-EP687027MOV
CSB-BP687027MOV
CSB-MP687027MOV
CSB-EP687027MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Glutamyl-tRNA (Gln) amidotransferase subunit A, mitochondrial (QRSL1), partial CSB-YP687028MOV
CSB-EP687028MOV
CSB-BP687028MOV
CSB-MP687028MOV
CSB-EP687028MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Transmembrane channel-like protein 7 (TMC7), partial CSB-YP687029MOV
CSB-EP687029MOV
CSB-BP687029MOV
CSB-MP687029MOV
CSB-EP687029MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Tetraspanin-1 (TSPAN1), partial CSB-YP687030MOV1
CSB-EP687030MOV1
CSB-BP687030MOV1
CSB-MP687030MOV1
CSB-EP687030MOV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Probable inactive serine protease 37 (PRSS37) CSB-YP687031MOV
CSB-EP687031MOV
CSB-BP687031MOV
CSB-MP687031MOV
CSB-EP687031MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Protein phosphatase 1 regulatory subunit 42 (PPP1R42) CSB-YP687032MOV
CSB-EP687032MOV
CSB-BP687032MOV
CSB-MP687032MOV
CSB-EP687032MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Lung adenoma susceptibility protein 2 homolog (LAS2) CSB-YP687033MOV
CSB-EP687033MOV
CSB-BP687033MOV
CSB-MP687033MOV
CSB-EP687033MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis NAD-dependent protein deacetylase sirtuin-2 (SIRT2) CSB-YP687034MOV
CSB-EP687034MOV
CSB-BP687034MOV
CSB-MP687034MOV
CSB-EP687034MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Leukemia NUP98 fusion partner 1 homolog (LNP1) CSB-YP687035MOV
CSB-EP687035MOV
CSB-BP687035MOV
CSB-MP687035MOV
CSB-EP687035MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Uncharacterized protein C2orf53 homolog (QtsA-12646) CSB-YP687036MOV
CSB-EP687036MOV
CSB-BP687036MOV
CSB-MP687036MOV
CSB-EP687036MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Lanosterol 14-alpha demethylase (CYP51A1), partial CSB-YP687037MOV1
CSB-EP687037MOV1
CSB-BP687037MOV1
CSB-MP687037MOV1
CSB-EP687037MOV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×